238 related articles for article (PubMed ID: 35837063)
1. 3-Bromopyruvic acid regulates glucose metabolism by targeting the c-Myc/TXNIP axis and induces mitochondria-mediated apoptosis in TNBC cells.
Li J; Pan J; Liu Y; Luo X; Yang C; Xiao W; Li Q; Yang L; Zhang X
Exp Ther Med; 2022 Aug; 24(2):520. PubMed ID: 35837063
[TBL] [Abstract][Full Text] [Related]
2. 3-Bromopyruvate Inhibits the Growth and Glucose Metabolism of TNBC Xenografts in Nude Mice by Targeting c-Myc.
Pan JM; Li JC; Yang C; Xiao WF; Li QS; Luo XH; Zhang XD
Anticancer Agents Med Chem; 2023; 23(12):1421-1428. PubMed ID: 37038711
[TBL] [Abstract][Full Text] [Related]
3. Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway.
Yang L; Li J; Li Y; Zhou Y; Wang Z; Zhang D; Liu J; Zhang X
Exp Ther Med; 2021 Jun; 21(6):584. PubMed ID: 33850556
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.
Shen L; O'Shea JM; Kaadige MR; Cunha S; Wilde BR; Cohen AL; Welm AL; Ayer DE
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5425-30. PubMed ID: 25870263
[TBL] [Abstract][Full Text] [Related]
5. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN
FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386
[TBL] [Abstract][Full Text] [Related]
6. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
7. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
Liu XH; Zheng XF; Wang YL
Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage.
Chen Y; Feng X; Yuan Y; Jiang J; Zhang P; Zhang B
Cell Death Dis; 2022 Apr; 13(4):338. PubMed ID: 35414060
[TBL] [Abstract][Full Text] [Related]
9. Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease.
Li J; Chen L; Qin Q; Wang D; Zhao J; Gao H; Yuan X; Zhang J; Zou Y; Mao Z; Xiong Y; Min Z; Yan M; Wang CY; Xue Z
Neurobiol Dis; 2022 Feb; 163():105605. PubMed ID: 34973450
[TBL] [Abstract][Full Text] [Related]
10. 3-bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
Wang TA; Zhang XD; Guo XY; Xian SL; Lu YF
Oncol Rep; 2016 Mar; 35(3):1287-96. PubMed ID: 26708213
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Effect of 3-Bromopyruvate in Combination with Rapamycin Impacted Neuroblastoma Metabolism by Inhibiting Autophagy.
Gan L; Ren Y; Lu J; Ma J; Shen X; Zhuang Z
Onco Targets Ther; 2020; 13():11125-11137. PubMed ID: 33149623
[TBL] [Abstract][Full Text] [Related]
12. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
[TBL] [Abstract][Full Text] [Related]
13. KIFC1 promotes aerobic glycolysis in endometrial cancer cells by regulating the c-myc pathway.
Zhou K; Lin J; Dai M; He Y; Xu J; Lin Q
J Bioenerg Biomembr; 2021 Dec; 53(6):703-713. PubMed ID: 34729671
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Key Glycolytic Enzyme Hexokinase 2 Ameliorates Psoriasiform Inflammation in vitro and in vivo.
Zhuang L; Ma W; Jiao J
Clin Cosmet Investig Dermatol; 2023; 16():3229-3239. PubMed ID: 37965102
[TBL] [Abstract][Full Text] [Related]
15. The effect and mechanism of hexokinase-2 on cisplatin resistance in lung cancer cells A549.
Xie S; Li X; Zhao J; Zhang F; Shu Z; Cheng H; Liu S; Shi S
Environ Toxicol; 2024 May; 39(5):2667-2680. PubMed ID: 38224486
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].
Peng QP; Liang HJ; Zhou Q; Zhou JM; Fu XL; Zhong DP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1058-62. PubMed ID: 17672972
[TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
Yu Q; Dai W; Ji J; Wu L; Feng J; Li J; Zheng Y; Li Y; Cheng Z; Zhang J; Wu J; Xu X; Guo C
J Cell Mol Med; 2022 May; 26(10):3031-3045. PubMed ID: 35429101
[TBL] [Abstract][Full Text] [Related]
18. Physciosporin suppresses mitochondrial respiration, aerobic glycolysis, and tumorigenesis in breast cancer.
Taş İ; Varlı M; Son Y; Han J; Kwak D; Yang Y; Zhou R; Gamage CDB; Pulat S; Park SY; Yu YH; Moon KS; Lee KH; Ha HH; Hur JS; Kim H
Phytomedicine; 2021 Oct; 91():153674. PubMed ID: 34333327
[TBL] [Abstract][Full Text] [Related]
19. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
